AFib Leader Kardium is a specialized medical device company focusing on atrial fibrillation with the Globe System, presenting a strong cross-sell opportunity to electrophysiology labs, hospitals, and regional cardiac centers seeking integrated mapping and ablation solutions.

FDA Milestone Recent FDA approval for Globe Pulsed Field System and planned U.S. launch create near-term sales momentum in the American market, offering you a timely entry point and potential multi-year adoption cycle with key KOLs.

Funding Momentum Significant funding activity including a 250M round and international loan investments indicates strong investor confidence and the financial runway to expand sales, support, and training initiatives in North America and beyond.

Expansion Footprint Recent office expansion in Burnaby and the global footprint suggest scalable operations and an opportunity to bundle equipment, service, and support contracts with local clinical deployment and training programs.

Strategic Partnerships Engagements with integration and AV providers, plus collaboration potential with diagnostics and mapping partners, open doors for ecosystem partnerships, bundled solutions, and channel-driven go-to-market strategies.